Oragenics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Oragenics and other ETFs, options, and stocks.

About OGEN

Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. 

CEO
Janet Huffman
CEOJanet Huffman
Employees
3
Employees3
Headquarters
Sarasota, Florida
HeadquartersSarasota, Florida
Founded
1996
Founded1996
Employees
3
Employees3

OGEN Key Statistics

Market cap
4.34M
Market cap4.34M
Price-Earnings ratio
-0.15
Price-Earnings ratio-0.15
Dividend yield
Dividend yield
Average volume
502.14K
Average volume502.14K
High today
$0.1973
High today$0.1973
Low today
$0.19
Low today$0.19
Open price
$0.1935
Open price$0.1935
Volume
66.95K
Volume66.95K
52 Week high
$3.43
52 Week high$3.43
52 Week low
$0.1617
52 Week low$0.1617

People also own

Based on the portfolios of people who own OGEN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.